Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Eur J Gastroenterol Hepatol ; 30(7): 779-785, 2018 07.
Article in English | MEDLINE | ID: mdl-29505476

ABSTRACT

BACKGROUND AND AIMS: The diagnosis of spontaneous bacterial peritonitis (SBP) depends primarily on a polymorphonuclear leukocyte cell count more than 250/mm. This method is invasive, and not diagnostic in all variants of SBP; we aimed to assess serum homocysteine as a precise indicative marker for the diagnosis of all variants of SBP. PATIENTS AND METHODS: A total 323 consecutive ascitic patients were registered in this prospective work. Serum and ascitic fluid of homocysteine were evaluated utilizing an enzyme-linked immunosorbent assay. RESULTS: Participants were classified into a non-SBP group, including 262 participants and 61 patients with SBP. Serum and ascitic homocysteine were considerably elevated in the SBP group than in the non-SBP group (17.94±7.57 vs. 11.75±5.68 µmol/l; P<0.001 and 14.70±5.45 vs. 9.75±4.55 µmol/l; P<0.001). At a cutoff value of 17.79 µmol/l, serum homocysteine had 89.3% specificity and 95.1% sensitivity for distinguishing SBP (area under the curve: 0.932) and, at a cutoff value of 16.1 µmol/l, ascitic homocysteine had 84.4% specificity and 92.7% sensitivity for distinguishing SBP (area under the curve: 0.901). Both were positively correlated with the polymorphonuclear count, C-reactive protein, Child-Pugh score, and Model For End-Stage Liver Disease score as well as negatively correlated with the protein content in the ascitic fluid and estimated glomerular filtration rate. After SBP therapy, there was a marked reduction in serum and ascitic homocysteine levels. CONCLUSION: This study demonstrates that serum and ascitic homocysteine are considerably higher in SBP participants versus non-SBP patients. Serum homocysteine may provide a reliable and noninvasive diagnostic marker for all variants of SBP.


Subject(s)
Bacterial Infections/blood , Bacterial Infections/diagnosis , Homocysteine/blood , Peritonitis/blood , Peritonitis/diagnosis , Aged , Anti-Bacterial Agents/therapeutic use , Area Under Curve , Ascitic Fluid/metabolism , Bacterial Infections/drug therapy , Bacterial Infections/microbiology , Biomarkers/blood , Enzyme-Linked Immunosorbent Assay , Female , Humans , Male , Middle Aged , Peritonitis/drug therapy , Peritonitis/microbiology , Predictive Value of Tests , Prospective Studies , ROC Curve , Reproducibility of Results , Time Factors , Treatment Outcome , Up-Regulation
2.
J Egypt Soc Parasitol ; 39(1): 191-204, 2009 Apr.
Article in English | MEDLINE | ID: mdl-19530621

ABSTRACT

In this study, a total of 54 male patients with asymptomatic cases of lymphatic filariasis were selected from the known endemic governorates; Damietta, Sharkia, Gharbia and Dakahlia. Medical sheets were filled out for each case. Diagnosis was based on detection of circulating microfilariae by specific ELISA. Some were treated with Ivermectin, and Albendazole. The treated cases were parasitologic and serologic evaluated pre-treatment and post-treatment for two years follow-up.


Subject(s)
Albendazole/therapeutic use , Antigens, Helminth/blood , Filariasis/blood , Filariasis/parasitology , Ivermectin/therapeutic use , Albendazole/administration & dosage , Drug Therapy, Combination , Egypt , Filariasis/drug therapy , Filaricides/administration & dosage , Filaricides/therapeutic use , Humans , Ivermectin/administration & dosage , Male
SELECTION OF CITATIONS
SEARCH DETAIL
...